A protocol that works at Week 2 should produce comparable results at Week 8, which requires dose consistency within 5mcg across the entire study period
Given the benefits of tirzepatide on weight, waist circumference, and lipid parameters in addition to impressive improvements in glycaemic control, this medication appears to be ideally placed as first add-on therapy for individuals not at HbA1c target on metformin, particularly for those with T2D and excess adiposity (Table 2, clinical scenario A)
While topical products are generally considered lower risk, you should always consult your doctor before using any concentrated skin treatments while expecting
Lactobacillus and Bifidobacterium are commonly used species derived from the intestinal microbiota of healthy individuals
Approved medications include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)